Market Size of Japan Diagnostic Imaging Industry
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| Forecast Data Period | 2024 - 2029 |
| Historical Data Period | 2019 - 2022 |
| CAGR | 6.28 % |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Japan Diagnostic Imaging Market Analysis
The Japan Diagnostic Imaging Market is projected to register a CAGR of 6.28% over the forecast period (2022-2027).
The healthcare system has witnessed enormous challenges as a result of the COVID-19 pandemic. All outpatient treatments were postponed or restricted during the COVID-19 pandemic to reduce the risk of viral transmission as most chronic therapies were regarded as non-urgent. However, with the advent of the COVID-19 infection, lung imaging became a major part of COVID-19 diagnostics, as it helped diagnose the severity of the disease in the affected population. For instance, an article titled 'Computed tomography surveillance helps tracking COVID-19 outbreak' published in the Japanese Journal of Radiology in December 2020 indicated that a computed tomography surveillance program (CT-surveillance) could demonstrate the epidemiologic features of COVID-19 infection. Such activities helped the growth of the market during the COVID-19 pandemic.
The major factors augmenting the growth of the diagnostic imaging market in Japan include the rise in the prevalence of chronic diseases, increased adoption of advanced technologies in medical imaging, and the rise in the geriatric population.
According to the Statistics Bureau of Japan, the country is experiencing a 'super-aging' society both in rural and urban areas. As per the February 2021 article by the Public Relations Office of the Government of Japan, the percentage of people over the age of 65 years old in Japan is expected to reach 33.3% by the year 2036 and 38.4% by the year 2065. Moreover, the prevalence of chronic diseases is also increasing among the Japanese population, and more so among the geriatric population as they are more prone to diseases. But Japan is a developed country that has a developed healthcare system as well. The healthcare industry in Japan has well adopted new innovations and advancements for diagnosis. These factors have helped this diagnostic imaging market grow in Japan.
An article titled 'Developing diagnostic reference levels in Japan' published in the Japanese Journal of Radiology in November 2021 indicated that the use of radiological tests in the nation has been increasing significantly in recent years. The article also aimed at developing an infrastructure for the review of diagnostic references in the nation. Such activities are likely to propel the growth of the market over the forecast period.
However, the cost of diagnosis due to expensive instruments and side effects that follow the diagnostic imaging have been restraining the growth of this market.
